Functional (psychogenic) symptoms in Parkinson's disease

Movement Disorders

Volumn 28, Issue 12, 2013, Pages 1622-1627

  Pareés, Isabel ^a   Saifee, Tabish A ^a   Kojovic, Maja ^a,b   Kassavetis, Panagiotis ^a   Rubio Agusti, Ignacio ^a,c   Sadnicka, Anna ^a   Bhatia, Kailash P ^a   Edwards, Mark J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Attention; Functional overlay; Goal directed motor control; Parkinson's disease

Indexed keywords

DOPAMINE; LEVODOPA;

ADULT; AGED; ALTERNATIVE HYPOTHESIS; ANXIETY; ARTICLE; BASAL GANGLION; BODY MOVEMENT; BRADYKINESIA; BRAIN CELL; BRAIN DEPTH STIMULATION; CASE REPORT; CEREBELLUM DISEASE; CLINICAL EVALUATION; DELUSION; DEPRESSION; DETERIORATION; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; DYSPNEA; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; GAIT DISORDER; HAND TREMOR; HUMAN; IMPULSE CONTROL DISORDER; MALE; MOTOR CONTROL; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PERCEPTION; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RIGIDITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STIMULUS RESPONSE; SWEATING; SYMPTOM;

ATTENTION; FUNCTIONAL OVERLAY; GOAL-DIRECTED MOTOR CONTROL; PARKINSON'S DISEASE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SOMATOFORM DISORDERS; SYMPTOM ASSESSMENT;

EID: 84886410016     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25544     Document Type: Article

References (24)

1. Stone J, Carson A, Duncan R, et al. Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease." J Neurol 2012;259:33-38.
2. Onofrj M, Bonanni L, Manzoli L, Thomas A. Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies. Neurology 2010;74:1598-1606.
3. Onofrj M, Thomas A, Tiraboschi P, et al. Updates on somatoform disorders (SFMD) in Parkinson's disease and dementia with Lewy bodies and discussion of phenomenology. J Neurol Sci 2011;310:166-171.
4. Reuber M, Howlett S, Khan A, Grunewald RA. Non-epileptic seizures and other functional neurological symptoms: predisposing, precipitating, and perpetuating factors. Psychosomatics 2007;48:230-238.
5. Costa A, Peppe A, Carlesimo GA, Salamone G, Caltagirone C. Neuropsychological correlates of alexithymia in Parkinson's disease. J Int Neuropsychol Soc 2007;13:980-992.
6. Goetz CG, Wuu J, McDermott MP, et al. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord 2008;23:690-699.
7. Hallett M. Psychogenic parkinsonism. J Neurol Sci 2011;310:163-165.
8. Kranick S, Ekanayake V, Martinez V, Ameli R, Hallett M, Voon V. Psychopathology and psychogenic movement disorders. Mov Disord 2011;26:1844-1850.
9. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
10. Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol 1988;50:431-455.
11. Schwingenschuh P, Katschnig P, Seiler S, et al. Moving toward "laboratory-supported" criteria for psychogenic tremor. Mov Disord 2011;26:2509-2515.
12. Edwards MJ, Adams RA, Brown H, Parees I, Friston KJ. A Bayesian account of "hysteria." Brain 2012;135(pt 11):34953-512.
13. Friston KJ, Daunizeau J, Kilner J, Kiebel SJ. Action and behavior: a free-energy formulation. Biol Cybern 2010;102:227-260.
14. Lorenz J, Hauck M, Paur RC, et al. Cortical correlates of false expectations during pain intensity judgments-a possible manifestation of placebo/nocebo cognitions. Brain Behav Immun 2005;19:283-295.
15. Feldman H, & Friston KJ. Attention, uncertainty, and free-energy [serial online]. Front Hum Neurosci 2010;4:215.
16. Fourneret P, Jeannerod M. Limited conscious monitoring of motor performance in normal subjects. Neuropsychologia 1998;36:1133-1140.
17. Jueptner M, Stephan KM, Frith CD, Brooks DJ, Frackowiak RS, Passingham RE. Anatomy of motor learning. I. Frontal cortex and attention to action. J Neurophysiol 1997;77:1313-1324.
18. Redgrave P, Rodriguez M, Smith Y, et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci 2010;11:760-772.
19. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880.
20. Morrish PK, Sawle GV, Brooks DJ. Clinical and [18F] dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry 1995;59:597-600.
21. van Poppelen D, Saifee TA, Schwingenschuh P, et al. Attention to self in psychogenic tremor. Mov Disord 2011;26:2575-2576.
22. Roelofs K, de Bruijn ER, Van Galen GP. Hyperactive action monitoring during motor-initiation in conversion paralysis: an event-related potential study. Biol Psychol 2006;71:316-325.
23. Cojan Y, Waber L, Carruzzo A, Vuilleumier P. Motor inhibition in hysterical conversion paralysis. Neuroimage 2009;47:1026-1037.
24. Parees I, Kassavetis P, Saifee TA, et al. Failure of explicit movement control in patients with functional motor symptoms. Mov Dis 2013;28:517-523.